What is the recommended dose of Propylthiouracil (PTU) in the first trimester?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Propylthiouracil (PTU) in First Trimester

The recommended dose of propylthiouracil (PTU) during the first trimester of pregnancy is the lowest effective dose that maintains free T4 or free thyroxine index (FTI) in the high-normal range, typically starting at 100-300 mg daily divided into three doses. 1, 2

Dosing Guidelines for PTU in First Trimester

  • PTU is the preferred antithyroid medication during the first trimester of pregnancy due to lower risk of congenital abnormalities compared to methimazole 1, 3
  • Initial dosing typically ranges from 100-300 mg daily, divided into three doses (e.g., 100 mg three times daily) 2, 4
  • The goal is to use the lowest possible dose that effectively controls maternal hyperthyroidism while minimizing fetal exposure 1, 5
  • Regular monitoring of thyroid function every 2-4 weeks is essential to adjust medication dosage appropriately 1

Monitoring During Treatment

  • Free T4 or FTI should be monitored every 2-4 weeks to guide dosage adjustments 1
  • The target is to maintain free T4 or FTI in the high-normal range rather than normalizing TSH 1, 5
  • TSH levels should be checked at least once per trimester 1
  • Monitor for side effects of PTU, particularly hepatotoxicity (fatigue, nausea, anorexia, fever, jaundice) 2, 4

Important Considerations

  • PTU crosses the placental membrane and can affect fetal thyroid function, so using the minimal effective dose is crucial 2, 6
  • In many pregnant women, thyroid dysfunction diminishes as pregnancy progresses, allowing for potential dose reduction or even discontinuation several weeks before delivery 2
  • After the first trimester, consider switching from PTU to methimazole due to the risk of maternal hepatotoxicity with continued PTU use 2, 3
  • PTU can cause severe liver injury, which appears to be idiosyncratic rather than dose-related 7, 4

Cautions and Contraindications

  • Inadequately treated hyperthyroidism increases risks of preeclampsia, preterm delivery, heart failure, and possibly miscarriage 1, 5
  • PTU may interact with anticoagulants, beta-blockers, digitalis glycosides, and theophylline, requiring dose adjustments of these medications 2
  • Patients should be instructed to immediately discontinue PTU and contact their physician if they develop symptoms of liver dysfunction (fatigue, nausea, anorexia, fever, pharyngitis, or malaise) 2, 4

Evidence on Fetal Effects

  • Studies comparing PTU and methimazole have shown no significant differences in fetal thyroid status when mothers are maintained on appropriate doses 6
  • Both low and high doses of PTU have been associated with altered fetal thyroid function, emphasizing the need for individualized dosing based on maternal thyroid status rather than using uniformly low doses 6

References

Guideline

Management of Hyperthyroidism in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The safety of methimazole and propylthiouracil in pregnancy: a systematic review.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Research

Propylthiouracil hepatitis: report of a case and extensive review of the literature.

Journal of pediatric endocrinology & metabolism : JPEM, 2012

Research

Management of hyperthyroidism during pregnancy and lactation.

European journal of endocrinology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.